Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Cipralex® for Anxiety Disorders in Adolescents (CAP-E)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2011 by University of Ottawa.
Recruitment status was:  Recruiting
Sponsor:
Collaborator:
H. Lundbeck A/S
Information provided by:
University of Ottawa
ClinicalTrials.gov Identifier:
NCT01293838
First received: February 10, 2011
Last updated: NA
Last verified: January 2011
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2012
  Estimated Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)